Remember
 

$MGEN Miragen Therapeutics presented results from its ongoing Phase 1 trial of MRG-106 in patients with the mycosis fungoides form of cutaneous T-cell lymphoma.


 5 days ago by corporatealerts  •  Posted on Friday, October 13th at 5:04 AM MST  •  0 REACTIONS

React to the Post Above with Your Unique Insight
 

Global Streams

 
PulseStream
SpecStream
UserStream
EchoStream